Patents by Inventor Michael Econs

Michael Econs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8586317
    Abstract: The present invention relates to methods of diagnosing hypophosphatemic disorders.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: November 19, 2013
    Assignees: Advanced Research & Technology Institute, Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik
    Inventors: Michael Econs, Kenneth E. White, Tim Matthias Strom, Thomas Meitinger
  • Publication number: 20120064544
    Abstract: The present invention relates to methods of diagnosing hypophosphatemic disorders.
    Type: Application
    Filed: April 11, 2011
    Publication date: March 15, 2012
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Patent number: 7947810
    Abstract: The present invention relates to a kit for diagnosing a disorder comprising a reagent that detects FGF23 polypeptides and mutant FGF23 polypeptides.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: May 24, 2011
    Assignees: Advanced Research & Technology Institute, Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Patent number: 7745406
    Abstract: The present invention relates to a kit for diagnosing a disorder comprising a reagent that detects FGF23 polypeptides and mutant FGF23 polypeptides.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: June 29, 2010
    Assignees: Advanced Research & Technology Institute, Ludwig-Maximilians-Universitat Munchen Abteilung Medizinische Genetik
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Publication number: 20090311792
    Abstract: The present invention relates to a kit for diagnosing a disorder comprising a reagent that detects FGF23 polypeptides and mutant FGF23 polypeptides.
    Type: Application
    Filed: November 7, 2007
    Publication date: December 17, 2009
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Publication number: 20080241946
    Abstract: The present invention relates to a kit for diagnosing a disorder comprising a reagent that detects FGF23 polypeptides and mutant FGF23 polypeptides.
    Type: Application
    Filed: November 7, 2007
    Publication date: October 2, 2008
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Patent number: 7314618
    Abstract: The present invention relates to antibodies that bind to FGF23 polypeptides and to FGF23 mutant polypeptides.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: January 1, 2008
    Assignees: Advanced Research and Technology Institute, Ludwig-Maximilians-Universtat Munchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Patent number: 7223563
    Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: May 29, 2007
    Assignees: Advanced Research and Technology Institute, Ludwig-Maximilians-Universitat Muchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Publication number: 20030181379
    Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.
    Type: Application
    Filed: March 4, 2003
    Publication date: September 25, 2003
    Applicant: Advanced Research & Technology Institute and Ludwig-Maximilians-Universitat Munchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Publication number: 20020156001
    Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.
    Type: Application
    Filed: July 10, 2001
    Publication date: October 24, 2002
    Applicant: Advanced Research & Technology Institute and Ludwig-Maximilians-Universitat Munchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger